These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pooled analysis of two randomized, open-label studies comparing the effects of nomegestrol acetate/17β-estradiol and drospirenone/ethinyl estradiol on bleeding patterns in healthy women. Mansour D; Westhoff C; Kher U; Korver T Contraception; 2017 Apr; 95(4):390-397. PubMed ID: 28011288 [TBL] [Abstract][Full Text] [Related]
4. Cycle control with triphasic norgestimate and ethinyl estradiol, a new oral contraceptive agent. Andolsek KM Acta Obstet Gynecol Scand Suppl; 1992; 156():22-6. PubMed ID: 1324553 [TBL] [Abstract][Full Text] [Related]
5. [Efficacy and safety of a combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 µg in a 24+4-day regimen in China]. Caiyan W; Wen D; Qinping L; Huan S; Ziyan H; Liangdan T; Zheng'ai X; Yufeng L; Shulan Z; Baihua D; Xiaoyan X; Mulan R; Xiaomao L; Youdi X; Zhisong M; Meiqing X; Hongyu W; Zirong H Zhonghua Fu Chan Ke Za Zhi; 2014 May; 49(5):355-9. PubMed ID: 25030732 [TBL] [Abstract][Full Text] [Related]
6. Scheduled and unscheduled bleeding patterns with two combined hormonal contraceptives: application of new recommendations for standardization. Hampton RM; Fisher AC; Pagano S; LaGuardia KD Fertil Steril; 2009 Aug; 92(2):434-40. PubMed ID: 18930189 [TBL] [Abstract][Full Text] [Related]
7. Bleeding profile of a flexible extended regimen of ethinylestradiol/drospirenone in US women: an open-label, three-arm, active-controlled, multicenter study. Jensen JT; Garie SG; Trummer D; Elliesen J Contraception; 2012 Aug; 86(2):110-8. PubMed ID: 22281416 [TBL] [Abstract][Full Text] [Related]
8. Cycle control with a 21-day compared with a 24-day oral contraceptive pill: a randomized controlled trial. Lynen RF Obstet Gynecol; 2010 Apr; 115(4):867. PubMed ID: 20308855 [No Abstract] [Full Text] [Related]
9. Efficacy, safety, and tolerability of a monophasic oral contraceptive containing nomegestrol acetate and 17β-estradiol: a randomized controlled trial. Westhoff C; Kaunitz AM; Korver T; Sommer W; Bahamondes L; Darney P; Verhoeven C Obstet Gynecol; 2012 May; 119(5):989-99. PubMed ID: 22525910 [TBL] [Abstract][Full Text] [Related]
10. Cycle control and bleeding pattern of a 24/4 regimen of drospirenone 3 mg/ethinylestradiol 20 μg compared with a 21/7 regimen of desogestrel 150 μg/ethinylestradiol 20 μg: a pooled analysis. Anttila L; Neunteufel W; Petraglia F; Marr J; Kunz M Clin Drug Investig; 2011; 31(8):519-525. PubMed ID: 21721590 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris. Lucky AW; Henderson TA; Olson WH; Robisch DM; Lebwohl M; Swinyer LJ J Am Acad Dermatol; 1997 Nov; 37(5 Pt 1):746-54. PubMed ID: 9366821 [TBL] [Abstract][Full Text] [Related]
12. Comparison of a novel norgestimate/ethinyl estradiol oral contraceptive (Ortho Tri-Cyclen Lo) with the oral contraceptive Loestrin Fe 1/20. Hampton RM; Short M; Bieber E; Bouchard C; Ayotte N; Shangold G; Fisher AC; Creasy GW Contraception; 2001 Jun; 63(6):289-95. PubMed ID: 11672549 [TBL] [Abstract][Full Text] [Related]
13. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol. Akerlund M; Røde A; Westergaard J Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004 [TBL] [Abstract][Full Text] [Related]
14. Bleeding pattern with drospirenone 3 mg+ethinyl estradiol 20 mcg 24/4 combined oral contraceptive compared with desogestrel 150 mcg+ethinyl estradiol 20 mcg 21/7 combined oral contraceptive. Anttila L; Kunz M; Marr J Contraception; 2009 Nov; 80(5):445-51. PubMed ID: 19835718 [TBL] [Abstract][Full Text] [Related]
15. Effects of an extended flexible regimen of an oral contraceptive pill containing 20 μg ethinylestradiol and 3 mg drospirenone on menstrual-related symptoms: a randomised controlled trial. Machado RB; Pompei LM; Badalotti M; Ferriani R; Cruz AM; Nahas E; Maia H Eur J Contracept Reprod Health Care; 2017 Feb; 22(1):11-16. PubMed ID: 27684740 [TBL] [Abstract][Full Text] [Related]
17. Cycle control, tolerability, and satisfaction among women switching from 30-35 microg ethinyl estradiol-containing oral contraceptives to the triphasic norgestimate/25 microg ethinyl estradiol-containing oral contraceptive Ortho Tri-Cyclen LO. Poindexter AN; Burkman R; Fisher AC; LaGuardia KD Int J Fertil Womens Med; 2003; 48(4):163-72. PubMed ID: 13677549 [TBL] [Abstract][Full Text] [Related]
18. Clinical experience with a new norgestimate-containing oral contraceptive. Huber J Int J Fertil; 1991; 36 Suppl 1():25-31. PubMed ID: 1678378 [TBL] [Abstract][Full Text] [Related]
19. Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen. Weisberg E; Merki-Feld GS; McGeechan K; Fraser IS Contraception; 2015 Feb; 91(2):121-6. PubMed ID: 25459098 [TBL] [Abstract][Full Text] [Related]
20. A comparison of bleeding patterns and cycle control using two transdermal contraceptive systems: a multicenter, open-label, randomized study. Gruber D; Skřivánek A; Serrani M; Lanius V; Merz M Contraception; 2015 Feb; 91(2):105-12. PubMed ID: 25453582 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]